omeprazole XR-ODT

Trials studying omeprazole XR-ODT

• phase1An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitisrecruitingn=25
• phase3Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Diseasecompletedn=145
• phase1A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancerrecruitingn=136
• phase3A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapyactive not recruitingn=420
• phase1A Multiple Dose Study of LY3502970 in Healthy Participantscompletedn=26
• phase1An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substratescompletedn=23
• phase1A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjectscompletedn=40
• phase1Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxincompletedn=13